Mark S. Blumenkranz - Jul 15, 2021 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role
Director
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Mark S. Blumenkranz
Stock symbol
ISEE
Transactions as of
Jul 15, 2021
Transactions value $
$0
Form type
4
Date filed
7/19/2021, 04:13 PM
Previous filing
Jun 7, 2021
Next filing
Nov 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise +5K 5K Jul 15, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -5K -33.33% $0.00 10K Jul 15, 2021 Common Stock 5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2 On July 15, 2020, the Reporting Person was granted 15,000 restricted stock units, which vest annually with respect to 1/3rd of the shares underlying such award until the third anniversary of the grant date, subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.